Status:
RECRUITING
Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients
Lead Sponsor:
Peking University First Hospital
Conditions:
Prediction Model
Eligibility:
All Genders
18-100 years
Brief Summary
Early prediction of acute kidney injury (AKI) may provide a crucial opportunity for AKI prevention. To date, no prediction model targeting AKI among general hospitalized patients in developing countri...
Detailed Description
Early prediction of acute kidney injury (AKI) may provide a crucial opportunity for AKI prevention. To date, no prediction model targeting AKI among general hospitalized patients in developing countri...
Eligibility Criteria
Inclusion
- Adult patients (18 years and older) admitted to five hospitals during the study period
Exclusion
- Have less than 2 documented serum creatinine (Scr) measurements during hospitalization
- Being diagnosed with end-stage renal disease (ESRD)
- Maintained on dialysis or had an initial Scr greater than or equal to 4.0 mg/dL at admission
- Developed AKI prior to admission or within 24 hours after admission
- Length of stay shorter than 24 hours
- Underwent kidney transplantation or nephrectomy during hospitalization
- With all Scr measurements lower than or equal to 0.6 mg/dL from 90 days prior to admission until discharge.
Key Trial Info
Start Date :
February 28 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
161876 Patients enrolled
Trial Details
Trial ID
NCT06597838
Start Date
February 28 2023
End Date
December 30 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034